The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

This royalty-focused biotech with a broad drug portfolio reported a notable insider sale amid strong stock performance.

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Transcend Therapeutics, Inc. (Transcend) announce that the two companies entered ...

Collegium Pharmaceutical, a leader in abuse-deterrent pain therapies, saw its Chief Commercial Officer trim his stake by more ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

In today's Pharmaceutical Executive Daily, Novartis agrees to acquire Excellergy for up to $2 billion to advance a ...

Is WST a good stock to buy? We came across a bullish thesis on West Pharmaceutical Services, Inc. on MaxDividends’s Substack.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Collegium ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of ...